Constantinos Zamboglou

専門分野: Clinical oncologist
13年の経験
話します:
German, English
オンラインコンサルテーション：利用可能
勤務先: キプロス, キプロス, German Medical Institute (GMI)
ザンボグロウ博士はフライブルク大学で前立腺がん研究を主導しており、放射線治療の専門医認定を受けています。精密放射線腫瘍学を専門としています。
- ドイツ放射線腫瘍学会の専門家パネルメンバー
- 前立腺がん研究に対するヘルマン・ホルツハウゼン賞受賞
- 放射線腫瘍学の技術に関する多数の出版物
- インターベンショナル放射線腫瘍学部門の責任者

Constantinos Zamboglou医師とのパッケージ取引を探る

手術を選択

ESTRO-ACROPガイドライン専門医による前立腺がんオンライン診療

$259

パッケージあたり

パッケージにはクリニックが提供する標準的な医療サービスと宿泊、送迎などの追加特典が含まれます。

Constantinos Zamboglouとのオンラインコンサルテーション

便利で簡単

100%安全で機密

$225

医師のサービス

調子はいかがですか？

1 の 3

この医師の情報は完全で明確です

強く反対

強く賛成

資格

Constantinos Zamboglou is a radiation oncologist who treats prostate cancer. He is a member of the ESTRO-ACROP guideline committee and the German expert panel for prostate cancer. Zamboglou currently holds leadership roles at the German Medical Institute in Cyprus and the University of Freiburg.

Specialization and Oncology Focus

Zamboglou treats patients using interventional radiation oncology and precision methods for prostate cancer. He uses specialized techniques to target tumors while sparing healthy tissue. He performs several procedures:

Brachytherapy for prostate cancer — a treatment that puts radioactive sources inside the body to kill cancer cells
CyberKnife robotic radiosurgery — a non-invasive treatment that delivers high-dose radiation with sub-millimeter precision
Targeted and hormone therapy
Immunotherapy and chemotherapy
Stereotactic Body Radiotherapy (SBRT)

Professional Career

Since 2022 – Vice Medical Director at the German Medical Institute (GMI) in Limassol, Cyprus.
Since 2022 – Prostate cancer research group leader at the Medical Center University of Freiburg.
2021–2022 – Advanced Clinician Scientist in the Bertha-Ottenstein program at Freiburg.
2021 – Head of the Section of Interventional Radiation Oncology at University of Freiburg.
Since 2019 – Consultant at the Department of Radiation Oncology, University of Freiburg.
2017–2020 – Clinician Scientist at the Bertha-Ottenstein program, University of Freiburg, Germany.
2013–2019 – Resident at the Medical Center University of Freiburg.

Education and Training

2021–2023 – Master of Health Business Administration (MHBA) at Friedrich Alexander University, Germany.
2022 – ISO 9001:2015 quality management training in Nicosia, Cyprus.
2020 – Habilitation in Radiation Oncology at the University of Freiburg.
2019 – Board certification in Radiotherapy and Radiation Oncology.
2018 – German drug law and Good Clinical Practice (GCP) training at University of Freiburg.
2012 – Doctoral thesis at the Institute of Pharmacology and Toxicology I, Freiburg, awarded summa cum laude.
2008–2013 – Medical degree from Albert-Ludwigs-Universität Freiburg, Germany.
2006–2008 – Medical studies at Semmelweis University Budapest, Hungary.

Awards and Recognition

2023 – Annual ARO study prize from the German Cancer Foundation for the HypoFocal-SBRT study.
2021 – Best Abstract award at the EMUC congress in Athens, Greece.
2020 – Herman-Holthusen Award from the German Society of Radiation Oncology (DEGRO).
2019 – Poster prize at the Uro-Oncological Symposium in Magdeburg.
2017 – Poster prize at the DEGRO annual meeting in Berlin.
2010 – Sanofi-Aventis poster prize at the German Society of Pharmacology annual meeting in Mainz.